This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Kyle Knouse, Ph.D.
Co-Founder and Director of Chemistry at Elsie Biotechnologies
Speaker

Profile

Kyle Knouse, Ph.D., from Gettysburg, Pennsylvania, earned his B.S. in Chemistry at Temple University in 2016 and his Ph.D. at the Scripps Research Institute in 2021. He co-founded Elsie Biotechnologies in 2021 and serves as its Director of Chemistry. Outside work, his interests include collecting plants, hiking, and exploring the world with his dog, Kilo.

Agenda Sessions

  • The Next-generation of Oligonucleotide Chemistry Using the P(V) Platform

    11:45am